SEC Filings | Context Therapeutics Inc.

Filing date	Description	Form	View
Jul 23, 2021	CORRESP	CORRESP	View HTML 0001193125-21-223075.pdf 0001193125-21-223075.rtf
Nov 14, 2022	CORRESP	CORRESP	View HTML 0001628280-22-029839.pdf 0001628280-22-029839.rtf 0001628280-22-029839.xls
Mar 22, 2021	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	DRS	View HTML 0000950123-21-003689.pdf 0000950123-21-003689.rtf 0000950123-21-003689.xls
Oct 19, 2021	EFFECT	EFFECT	View HTML 9999999995-21-003933.pdf 9999999995-21-003933.rtf 9999999995-21-003933.xls
Dec 16, 2021	EFFECT	EFFECT	View HTML 9999999995-21-004733.pdf 9999999995-21-004733.rtf 9999999995-21-004733.xls
Apr 07, 2022	EFFECT	EFFECT	View HTML 9999999995-22-000861.pdf 9999999995-22-000861.rtf 9999999995-22-000861.xls
Nov 10, 2022	EFFECT	EFFECT	View HTML 9999999995-22-003259.pdf 9999999995-22-003259.rtf 9999999995-22-003259.xls
Nov 16, 2022	EFFECT	EFFECT	View HTML 9999999995-22-003318.pdf 9999999995-22-003318.rtf 9999999995-22-003318.xls
Oct 20, 2021	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	424B4	View HTML 0001193125-21-303138.pdf 0001193125-21-303138.rtf 0001193125-21-303138.xls
Dec 17, 2021	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	424B4	View HTML 0001628280-21-025277.pdf 0001628280-21-025277.rtf 0001628280-21-025277.xls

Data provided by Kaleidoscope.